Literature DB >> 20032585

Deficiency of clusterin inhibits neointimal hyperplasia after vascular injury.

Takahiro Shirasawa1, Masaaki Miyata, Hideyuki Eto, Narisato Hamada, Yuichi Akasaki, Takahiro Miyauchi, Yuko Furusho, Koji Orihara, Shuichi Hamasaki, Bruce J Aronow, Jonathan D Smith, Chuwa Tei.   

Abstract

AIM: Increased clusterin mRNA and protein levels have been detected in various tissues undergoing stress, and we previously reported that clusterin is markedly induced in media and neointima following vascular injury. The present study therefore investigated the impact of clusterin on neointimal hyperplasia following vascular injury. METHODS AND
RESULTS: As compared with wild-type mice, clusterin knockout mice (clusterin-KO) demonstrated a significant decrease of the intima/media ratio 4 weeks after cuff placement. Immunohistochemical analysis of injured femoral arteries in clusterin-KO demonstrated the accumulation of p53 in nuclei of neointimal vascular smooth muscle cells (VSMCs). Moreover, VSMCs from either clusterin-KO or rat VSMCs treated with clusterin-short-interfering (si) RNA subjected to static stretch exhibited significantly increased p53 and p21, and increased G1 cell cycle arrest as indicated by flow cytometry compared with VSMCs from wild-type mice.
CONCLUSION: Reduced clusterin expression reduced the proliferation of VSMCs and induced G1 arrest via p53 and p21. Clusterin therefore represents a promising molecular target to limit restenosis after coronary intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032585     DOI: 10.5551/jat.1917

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  6 in total

1.  Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease.

Authors:  Hong-Ren Yu; Ho-Chang Kuo; Eng-Yen Huang; Chi-Di Liang; Kao-Pin Hwang; I-Chun Lin; Jiunn-Ming Sheen; Tzu-Jou Wang; Chih-Lu Wang; Kuender D Yang
Journal:  Pediatr Cardiol       Date:  2010-08-15       Impact factor: 1.655

2.  Brain clusterin protein isoforms and mitochondrial localization.

Authors:  Sarah K Herring; Hee-Jung Moon; Punam Rawal; Anindit Chhibber; Liqin Zhao
Journal:  Elife       Date:  2019-11-18       Impact factor: 8.140

3.  Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation.

Authors:  Jong Chul Won; Cheol-Young Park; Sang Woo Oh; Eon Sook Lee; Byung-Soo Youn; Min-Seon Kim
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

Review 4.  Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?

Authors:  Ning Yang; Qin Qin
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

5.  Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats.

Authors:  Ning Yang; Bo Dong; Jinyu Yang; Yang Li; Lu Kou; Yue Liu; Qin Qin
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

6.  Rosuvastatin Decreases the Formation of Neointima by Increasing Apo J, Reducing Restenosis after Balloon Injury in Rats.

Authors:  Paulo Magno Martins Dourado
Journal:  Arq Bras Cardiol       Date:  2018-10       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.